Navigation Links
Genomic Health Announces First Quarter 2013 Financial Results and Business Progress
Date:5/2/2013

ble genomic information to personalize cancer treatment decisions.  The company's lead product, the Oncotype DX® breast cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer and has been shown to predict the likelihood of recurrence in ductal carcinoma in situ (DCIS).  In addition to this widely adopted test, Genomic Health provides the Oncotype DX colon cancer test, the first multi-gene expression test developed for the assessment of risk of recurrence in patients with stage II and stage III disease.  As of March 31, 2013, more than 19,000 physicians in over 70 countries had ordered approximately 350,000 Oncotype DX tests.  Genomic Health has a robust pipeline focused on developing tests to optimize the treatment of prostate and renal cell cancers, as well as additional treatment decisions in breast and colon cancers.  The company is based in Redwood City, California with European headquarters in Geneva, Switzerland.  For more information, please visit, www.GenomicHealth.com. To learn more about Oncotype DX tests, visit:
SOURCE Genomic Health, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Family Tree DNAs Genomics Research Center Facilitates Discovery of Extremely Ancient Root to the Human Y Chromosome Phylogenetic Tree
2. H3 Biomedicine and BGI Announce Collaboration to Develop and Share Crucial Cancer Genomic Sequencing Data
3. Rosetta Genomics Receives Two Key U.S. Patent Allowances
4. Genomic Health Announces Year-End 2012 Financial Results, Provides 2013 Financial Outlook
5. Genomic Health to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, February 6, 2013
6. Health Diagnostic Laboratory, Inc. and Global Genomics Group join forces to form a new scientific process
7. Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
8. Genomic Research Service Provider DNA Link Purchases 10 Ion Proton Sequencers
9. Genomic Health Announces Third Quarter 2012 Financial Results and Business Progress
10. MediSapiens to Provide Bayer HealthCare Pharmaceuticals With a New Cloud Computing Application to Analyze and Visualize Multi-Dimensional Genomics Data
11. Keynote Presentation at Upcoming International Microbiology & Genomics Meeting to Highlight Ability of Pressure BioSciences Patented PCT Platform to Improve Testing for Biological Threat Organisms, Human Infectious Diseases, and Contaminated Food P
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... public offering of units. Each unit will consist of ... purchase common stock and Series B warrants to purchase ... offering would result in them beneficially owning more than ...
(Date:6/29/2015)... 29, 2015  Alimera Sciences, Inc. (NASDAQ: ALIM ... research, development and commercialization of prescription ophthalmic pharmaceuticals, today ... and Chief Financial Officer, will present at the 2015 ... at 8:00 a.m. ET at Le Parker Meridien Hotel ... The presentation will be webcast live and will be ...
(Date:6/29/2015)... , June 29, 2015 Regeneron ... that the Proceedings of the National Academy ... demonstrating that the Company,s proprietary VelociGene ® ... identification and preclinical validation of potential candidates that ... of Middle East Respiratory Syndrome (MERS). This involved ...
Breaking Medicine Technology:EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5
... Athera Biotechnologies AB and Dyax,Corp. (NASDAQ: ... entered into a,collaboration to discover and to ... of cardiovascular inflammatory diseases., The collaboration ... Athera,scientific founders, Professors Frostegard and de Faire ...
... Amylin,s integrated neurohormonal ... approach to obesity pharmacotherapy, SAN DIEGO, Oct. 1 ... data for its pipeline obesity,candidates will be presented at the ... 3-7. The Obesity Society,s annual,meeting is one of the largest ...
Cached Medicine Technology:Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 2Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 3Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 4Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 2Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 3Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 4Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 5Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 6Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society 7
(Date:6/29/2015)... YORK, NEW YORK (PRWEB) , ... June 29, ... ... sleep apnea (OSA) is now being offered at NewYork-Presbyterian/Weill Cornell Medical Center. The ... Drug Administration and is an alternative to continuous positive airway pressure (CPAP), the ...
(Date:6/29/2015)... ... 2015 , ... National HealthCare Associates recently released a list ... 40-center nursing home group. Sixteen of their centers were rated “Best in Class” ... one or more customer service areas. Those centers received the prestigious “Customer Experience ...
(Date:6/29/2015)... ... , ... With Urgent Care Medicine now serving a vital role in our ... Care Medicine and the Medical Society of Delaware to provide its latest professional development ... care professionals. , According to Matthew Bader, Exam Master CEO and President, “This resource ...
(Date:6/29/2015)... , ... June 29, 2015 , ... OR Manager announced ... revitalized look and feel, as well as a redesigned logo and weekly eLetter. The ... but is now more user-friendly and easier to navigate. , In addition to ...
(Date:6/29/2015)... ... ... The Food Safety and Technology Research Centre under the ... (PolyU) has developed a new method for rapid authentication of edible oils and ... in food safety, and becomes particularly important with the emergence and widespread use ...
Breaking Medicine News(10 mins):Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 2Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 3Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 4Health News:National HealthCare Centers Receive 'Customer Experience Awards' 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 3Health News:National HealthCare Centers Receive 'Customer Experience Awards' 4Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 2Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 3Health News:OR Manager Launches New Website 2Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2
... , THURSDAY, Dec. 23 (HealthDay News) -- Flu activity in the ... but government health officials expect flu viruses will infect more people ... for Disease Control and Prevention has already received several reports of ... from New York and one from Texas. From Oct. 3 ...
... BOSTON--Dana Farber/Harvard Cancer Center (DF/HCC) will launch a new ... research. It will be administered in collaboration with the ... of the United States District Court for the District ... cy pres ("near as possible") distribution of unclaimed funds ...
... (HealthDay News) -- How do people recognize an image of a ... replica such as a doll or mannequin? A new study suggests ... distinguish real faces from those that are not. "There,s something ... are on and someone is home," study co-author Thalia Wheatley of ...
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, ... been able to help being so mean. That,s because ... less able to read the emotions of others, a new ... test how well participants could judge how others were feeling. ...
... , FRIDAY, Dec. 24 (HealthDay News) -- The lack ... Christmas may put their health at risk, British sleep experts ... may not harm Santa,s long-term health, there are short-term risks, ... the University of Warwick,s Warwick Medical School. The lack ...
... patients who stick to a vegetarian diet, according to a ... Journal of the American Society Nephrology (CJASN). The results ... disease patients avoid accumulating toxic levels of this mineral in ... the body of phosphorus, which is found in dietary proteins ...
Cached Medicine News:Health News:Flu Activity Low So Far, But More Cases to Come: CDC 2Health News:Dana Farber/Harvard Cancer Center awarded $11.7M grant to support prostate cancer research 2Health News:Maybe Scrooge Couldn't Help Being Hard-Hearted 2Health News:Maybe Scrooge Couldn't Help Being Hard-Hearted 3Health News:Could Santa's Lack of Sleep on Christmas Eve Harm His Health? 2Health News:Kidney disease patients: Eat your veggies, reward your kidneys 2
Our 2.5v Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
3.5v Ophthalmic Diagnostic Set with AutoStep Coaxial Ophthalmoscope, Spot Retinoscope, Rechargeable Handle, and Soft Case. High-quality eyecare from the preferred name in diagnostic instruments....
... are standard in all Welch Allyn ... students, the 18335-SDS combines the superior ... the superior illumination of the Halogen ... of the Finnoff Transilluminator, and the ...
High-quality eyecare from the preferred name in diagnostic instruments....
Medicine Products: